Barrett et al. showed the cytotoxic potential of human CD19 mRNA-redirected T cells against the Nalm-6 human ALL cell line and K562 human erythroleukemic cell line engineered to express the CD19 antigen [15]. This evidence concerns the gene CD19 and acute lymphoblastic leukemia.